|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1981-4-13
|
|
pubmed:abstractText |
Preincubation of human platelet rich plasma with PGI2 in a concentration preventing collagen induced platelet aggregation abolished also platelet factor 3 availability brought about by collagen. Following PGI2 pretreatment no second wave aggregation could be elicited by ristocetin. However, primary aggregation as well as platelet factor 3 activity were only partially inhibited in this case and the inhibitory action of PGI2 was not increased by raising its concentration. Similarly, marked but not complete inhibition of platelet factor 3 availability was obtained when kaolin was used as activating agent.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0090-6980
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
935-45
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7008092-Blood Coagulation Factors,
pubmed-meshheading:7008092-Blood Platelets,
pubmed-meshheading:7008092-Collagen,
pubmed-meshheading:7008092-Epoprostenol,
pubmed-meshheading:7008092-Humans,
pubmed-meshheading:7008092-Kaolin,
pubmed-meshheading:7008092-Kinetics,
pubmed-meshheading:7008092-Platelet Aggregation,
pubmed-meshheading:7008092-Platelet Factor 3,
pubmed-meshheading:7008092-Prostaglandins,
pubmed-meshheading:7008092-Ristocetin
|
|
pubmed:year |
1980
|
|
pubmed:articleTitle |
Inhibition of platelet factor 3 availability by prostacyclin.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
